Exogenous and endogenous HDAC inhibitor effects in Rubinstein-Taybi syndrome models
Elisabetta Di Fede, Emerenziana Ottaviano, Paolo Grazioli, Camilla Ceccarani, Chiara Parodi, Elisa Adele Colombo, G. Bassanini, Marco Severgnini, Donatella Milani, Elvira Verduci, Thomas Vaccari, Valentina Massa, Elisa Borghi, Cristina Gervasini
This study investigates the effects of HDAC inhibitors in RSTS models, showing molecular rescue and microbiota changes, and highlights the role of gut microbiota in chromatinopathy.
bioRxiv · Mar 31, 2020 · PreprintGenetics